Germany’s education and research ministry has declared satisfaction with the performance of the Neuroallianz Consortium over the past three years and said it will provide an extra €15 million in non-refundable grants.
The consortium comprises of research institutions such as the universities of Bonn and Duisburg-Essen and biotechnology and pharmaceutical companies. Their goal is to improve diagnostic methods and therapies for neurodegenerative diseases, like Alzheimer’s, Parkinson’s and epilepsy by using latest research findings.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.